Works matching IS 23988835 AND DT 2019 AND VI 2 AND IP 1

Results: 7
    1

    Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study.

    Published in:
    Health Science Reports, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1002/hsr2.107
    By:
    • Okimoto, Nobukazu;
    • Uemura, Yukari;
    • Yoshioka, Toru;
    • Arita, Shinobu;
    • Tsurukami, Hiroshi;
    • Otomo, Hajime;
    • Nishida, Satoshi;
    • Ogawa, Takayuki;
    • Hirao, Ken;
    • Ikeda, Satoshi;
    • Matsumoto, Hidehiro;
    • Toten, Yoriko;
    • Katae, Yuji;
    • Okazaki, Yuichi;
    • Nakagawa, Tsuyoshi;
    • Sakai, Akinori
    Publication type:
    Article
    2
    3

    Issue Information.

    Published in:
    Health Science Reports, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1002/hsr2.62
    Publication type:
    Article
    4
    5

    Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice.

    Published in:
    Health Science Reports, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1002/hsr2.104
    By:
    • Hulin, Cyrille;
    • Rubia, Javier;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos;
    • Katodritou, Eirini;
    • Hungria, Vania;
    • De Samblanx, Hadewijch;
    • Stoppa, Anne‐Marie;
    • Aagesen, Jesper;
    • Sargin, Deniz;
    • Sioni, Anastasia;
    • Belch, Andrew;
    • Diels, Joris;
    • Olie, Robert A.;
    • Robinson, Don;
    • Potamianou, Anna;
    • Velde, Helgi;
    • Delforge, Michel
    Publication type:
    Article
    6
    7